Prolonged exposure to indoor mold has been linked to symptoms of peripheral neuropathy in several clinical studies, though the connection remains one of the more contested areas in environmental medicine. Researchers have documented nerve conduction abnormalities, neural autoantibodies, and sensory deficits in people living or working in water-damaged buildings, and laboratory studies show that specific mycotoxins can damage nerve cells directly. But a sharp divide exists between clinicians who treat mold-related illness and mainstream allergy and immunology researchers who question the validity of the diagnosis altogether. The real picture is more complex than either camp tends to let on.
What Clinical Studies Have Found
The most direct evidence comes from a study of 119 patients who developed numbness, tingling, tremors, and muscle weakness after living in water-damaged, mold-contaminated homes. Nerve conduction testing revealed that the majority had measurable abnormalities: 55 had mixed sensory-motor polyneuropathy, 17 had purely motor neuropathy, and 27 had purely sensory neuropathy. Only 20 had symptoms without detectable nerve conduction changes. All groups, including those with normal nerve conduction, showed elevated levels of autoantibodies against neural tissue compared with 500 healthy controls.1PubMed. Neural autoantibodies and neurophysiologic abnormalities in patients exposed to molds in water-damaged buildings
A separate study compared 65 mold-exposed patients from Arizona, California, and Texas against 202 unexposed community members. The exposed group performed worse on 21 of 26 neurological and cognitive tests, including balance, reaction time, blink-reflex speed, color discrimination, visual field range, grip strength, verbal recall, and problem-solving tasks. The researchers attributed the findings to mycotoxin exposure, particularly trichothecenes produced by common indoor molds.2PubMed. Indoor mold exposure associated with neurobehavioral and pulmonary impairment: a preliminary report
These are not massive population studies. Both involved self-selected patients who sought medical care after developing symptoms in moldy environments. That selection bias matters, because people who feel sick are more likely to show up in a clinic than people who feel fine. Still, the nerve conduction findings in the first study are objective measurements, not self-reported symptoms, which gives them more weight than survey data alone.
How Mycotoxins Could Damage Nerves
Molds do not cause harm simply by being present. The concern centers on mycotoxins, which are toxic compounds certain mold species produce as part of their normal metabolism. When mold grows indoors, especially in wall cavities, ceiling spaces, and damp insulation, these toxins can become airborne on spore fragments and dust particles. Once inhaled, some mycotoxins can enter the body through the olfactory neurons in the nose, which connect directly to the brain.3PubMed. Mold and Mycotoxin Exposure and Brain Disorders
Animal research has demonstrated this pathway in action. When mice were exposed to satratoxin G, a toxin produced by the black mold Stachybotrys chartarum, the compound triggered cell death in olfactory sensory neurons and caused visible shrinkage of the olfactory nerve and the olfactory bulb of the brain within seven days. Mild brain inflammation followed.4PubMed Central. Satratoxin G from the black mold Stachybotrys chartarum evokes olfactory sensory neuron loss and inflammation in the murine nose and brain That is a cranial nerve being damaged by a mold toxin, which is neuropathy in the most literal sense.
More broadly, mycotoxins have been shown to provoke oxidative stress and inflammation in neural tissue. Ochratoxin A, one of the most studied mycotoxins, can cross the blood-brain barrier and damage neurons directly. A systematic review of ochratoxin A research detailed its ability to trigger cell death in neural tissue, promote neuroinflammation, and interfere with normal brain cell development.5PubMed Central. Unveiling the Neurotoxic Effects of Ochratoxin A and Its Impact on Neuroinflammation Lab experiments have confirmed that ochratoxin A is toxic to brain cells from multiple regions, with neurons in certain areas being more vulnerable than others.6PubMed. Selective toxicity of ochratoxin A in primary cultures from different brain regions
Other mycotoxins implicated in neurological harm include T-2 toxin, a trichothecene produced by Fusarium species, and various aflatoxins. A recent review noted that these compounds can induce neuronal damage, disrupt mitochondrial function, and interfere with neurotransmitter systems, with peripheral neuropathy listed among the associated clinical outcomes.7PubMed Central. Mycotoxins and neuropsychiatric symptoms: possible role in special refugee populations
The Autoimmune Angle
The nerve conduction study described earlier uncovered something beyond simple toxic damage: the mold-exposed patients had significantly elevated antibodies against their own nerve tissue. This suggests that mold exposure might trigger an autoimmune response in which the immune system mistakenly attacks the peripheral nerves, a mechanism similar to what happens in Guillain-Barré syndrome or chronic inflammatory demyelinating polyneuropathy. The fact that even the patients with symptoms but normal nerve conduction showed elevated neural autoantibodies hints that the immune response may precede detectable nerve damage.1PubMed. Neural autoantibodies and neurophysiologic abnormalities in patients exposed to molds in water-damaged buildings
This autoimmune pathway could help explain why some people develop persistent neuropathy long after leaving a moldy environment. If the immune system has been trained to attack nerve tissue, removing the initial trigger does not necessarily stop the damage. It also raises the possibility that mold-associated neuropathy is not purely a toxicological problem but partly an immunological one, which has implications for treatment. An immune-mediated neuropathy might respond to immune-modulating therapy, while a purely toxic neuropathy would depend more on eliminating exposure and allowing nerve regeneration.
The Scientific Pushback
Not everyone in the medical community accepts these findings. A critical review published in a leading allergy and immunology journal argued that “toxic mold syndrome” has been disproven as a clinical entity. The authors specifically called out common diagnostic practices, including testing homes for mold spores, measuring mycotoxins in urine, and testing patients for mold-specific antibodies, stating that none of these techniques have been validated or shown to be clinically relevant.8PubMed. The Myth of Mycotoxins and Mold Injury
The critique has some legitimate basis. Much of the mold illness literature relies on case series, clinical observations, and small cohort studies rather than large randomized controlled trials. No one has conducted the definitive experiment: randomly assigning people to mold-exposed and unexposed environments and tracking who develops neuropathy. For obvious ethical reasons, that study will never happen. The evidence therefore remains associational, and in medicine, association is not causation.
There is also a real problem with unvalidated commercial testing. Some practitioners charge patients for urine mycotoxin panels that have no established reference ranges, no proven connection to clinical disease, and no regulatory oversight. The existence of a cottage industry built around dubious tests does not disprove the underlying biology, but it does muddy the waters and make legitimate research harder to take seriously.
Where the skeptical position gets weaker is in dismissing the animal data and the mechanistic evidence. Mycotoxins are demonstrably neurotoxic in cell cultures and animal models. The question is not whether these compounds can harm nerve tissue; that has been shown repeatedly. The question is whether indoor mold exposure in real-world buildings delivers a sufficient dose to produce clinical neuropathy in humans. The honest answer is that we do not yet have the exposure data to settle that question definitively.
Beyond Mycotoxins Themselves
Mold does not just produce mycotoxins. All growing fungi release microbial volatile organic compounds, the chemicals responsible for that distinctive musty smell in damp buildings. These gases are produced in varying mixtures depending on the mold species and what it is feeding on. Even at very low concentrations, measured in parts per billion, microbial volatile organic compounds can cause headaches, dizziness, fatigue, brain fog, and skin irritation.9Archives of Clinical Toxicology. Role of microbial volatile compounds (mVOCs) in toxicity from molds-infested buildings: a case report These symptoms overlap substantially with what neuropathy patients report, and a person living in a moldy building is typically exposed to mycotoxins, volatile compounds, and mold spore fragments simultaneously. Teasing apart which component is driving which symptoms is genuinely difficult.
Water-damaged buildings also tend to harbor bacteria, dust mites, and chemical off-gassing from degraded building materials. The health effects attributed to mold may actually result from this entire cocktail of exposures. That complexity is part of why the science has been slow to resolve the question cleanly.
The Symptom Picture
People who develop neurological problems after mold exposure tend to report a cluster of symptoms that straddles the line between peripheral neuropathy and central nervous system involvement. A clinical review described a recognizable syndrome: numbness and tingling in the extremities, pain, tremors, balance problems, coordination difficulties, and movement abnormalities that can partly mimic established neurological diseases, but without a clear match to any single one.10Toxicology and Industrial Health. Neurologic and neuropsychiatric syndrome features of mold and mycotoxin exposure Cognitive symptoms like difficulty concentrating, memory problems, and slowed mental processing frequently accompany the physical nerve symptoms.
This mixed presentation is one reason conventional neurologists sometimes struggle with these patients. Pure peripheral neuropathy from, say, diabetes has a fairly predictable pattern. Mold-exposed patients tend to show up with a less tidy set of complaints that crosses into cognitive and psychiatric territory. From the clinician’s perspective, the symptom overlap with anxiety, depression, chronic fatigue, and fibromyalgia can make it tempting to attribute everything to a psychological cause, especially when the mainstream position is that “toxic mold syndrome” does not exist.
Chronic Inflammatory Response Syndrome
Some researchers frame mold illness not as a discrete toxicological injury but as a chronic inflammatory state triggered by the innate immune system. Chronic Inflammatory Response Syndrome, or CIRS, is described as a condition of immune dysregulation following respiratory exposure to water-damaged buildings, with symptoms simultaneously affecting multiple organ systems.11PubMed Central. Chronic inflammatory response syndrome: a review of the evidence of clinical efficacy of treatment Under this framework, neuropathy is one manifestation of a broader inflammatory cascade rather than a standalone diagnosis.
The CIRS concept is controversial. Proponents cite a body of clinical literature and biomarker panels. Critics point out that the diagnostic criteria were largely developed by a single research group, that the biomarkers used are nonspecific, and that the condition has not been recognized by major medical societies. Whether CIRS eventually gains mainstream acceptance or fades as a contested hypothesis remains to be seen. But for patients experiencing neuropathy symptoms in the context of mold exposure, the underlying idea that chronic inflammation could be driving nerve damage is at least biologically plausible.
Why Some People Seem More Vulnerable
A question that comes up repeatedly is why two people can live in the same moldy building and have completely different health outcomes. Genetic variation offers one possible explanation. Certain variations in the HLA-DR and HLA-DQ genes, which help the immune system recognize and clear foreign substances, appear to make some individuals less efficient at eliminating mycotoxins from their bodies.12PubMed. HLA gene variations and mycotoxin toxicity: Four case reports
Case reports have described individuals with specific HLA gene variants who developed severe symptoms after mold exposure that their housemates did not experience. In one case, a man with five susceptibility-associated HLA alleles developed significant illness after a brief acute exposure during cleaning. The researchers estimated that his genetic makeup made mycotoxin clearance so slow that even short-term exposure could effectively become chronic, with toxins lingering in blood and tissues for years.13Archives of Clinical Toxicology. Molds and mycotoxins indoors III: Three case reports This is case-report-level evidence, not population data, so extrapolating broadly is premature. But it offers a plausible biological mechanism for the wide variation in susceptibility that clinicians observe.
The Mast Cell Connection
Another piece of the puzzle involves mast cells, immune cells found throughout the body that release histamine and other inflammatory chemicals when activated. Mast cell activation syndrome has been associated with a range of neurological problems, including small fiber neuropathy, migraines, cognitive dysfunction, and autonomic nervous system dysfunction. Mycotoxin exposure is listed among the long-lasting hidden triggers that can drive mast cell activation.14PubMed Central. Neuropsychiatric Manifestations of Mast Cell Activation Syndrome and Response to Mast-Cell-Directed Treatment: A Case Series
Small fiber neuropathy is particularly worth highlighting here, because it is a form of nerve damage that does not show up on standard nerve conduction studies. Those tests measure the speed of signals in large nerve fibers. Small fiber neuropathy affects the thin, unmyelinated nerves responsible for pain and temperature sensation, and it requires a skin punch biopsy to diagnose definitively. This could account for some of the patients in the autoantibody study who had symptoms and elevated neural antibodies but normal nerve conduction results. If their small fibers were damaged while their large fibers remained intact, a standard nerve conduction study would miss it entirely.
What to Do If You Suspect Mold Is Affecting Your Nerves
If you are experiencing numbness, tingling, burning pain, muscle weakness, or balance problems and you live or work in a building with visible mold, water damage, or a persistent musty odor, the first practical step is removing yourself from the exposure. Many patients in the clinical literature reported symptom improvement after leaving the contaminated environment, though recovery timelines vary widely and some people have persistent deficits.
Getting a diagnosis can be frustrating. Standard neurological workups for neuropathy will check for diabetes, vitamin deficiencies, thyroid disease, autoimmune conditions, and alcohol use. These should absolutely be ruled out, since they are far more common causes of neuropathy than mold. If those come back negative and the history points to mold exposure, you may need to advocate for further testing. A skin punch biopsy for small fiber neuropathy density is a reasonable request if your nerve conduction studies look normal but your symptoms persist.
Be cautious about practitioners who lead with expensive and unvalidated testing panels. Urine mycotoxin testing, in particular, has not been established as a reliable clinical tool by mainstream medical standards. Environmental testing of your home by a qualified industrial hygienist can confirm the presence of mold, but interpreting what those results mean for your personal health is less straightforward than some testing companies suggest.
The Gut-Brain Pathway
An emerging area of research looks at how environmental toxins, including mycotoxins, may affect the nervous system indirectly through the gut. Mycotoxin-contaminated food and inhaled particles that are swallowed can disrupt the gut microbiome, and growing evidence links gut microbiome disruption to neuroinflammation and neurological disease through immune and hormonal signaling pathways.15Taylor & Francis Online. An integrative exploration of environmental stressors on the microbiome-gut-brain axis and immune mechanisms promoting neurological disorders This so-called gut-brain axis is still being mapped out, and its relevance to mold-specific neuropathy is speculative at this point. But it adds another potential route by which mold exposure could affect peripheral nerve health, one that does not require mycotoxins to reach nerve tissue directly.
People with mold exposure frequently report gastrointestinal symptoms alongside their neurological complaints, including nausea, abdominal pain, and changes in bowel habits. Whether those gut symptoms are driving or merely accompanying the neuropathy is an open question, but the overlap is consistent with the gut-brain hypothesis. Research in this area is early-stage, and anyone promising definitive gut-based treatments for mold neuropathy is ahead of the evidence.